Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL11969372

CCCC[N+](CCCC)(CCCC)CCCC.[BH3-]CCCC(c1cccc2ccccc12)(c1cccc2ccccc12)c1cccc2ccccc12

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 1/20 0.33
SLC22A1 O15245 1/20 0.32
GAA P10253 4/20 0.32
KDM4E B2RXH2 3/20 0.32
NPC1 O15118 3/20 0.32
ALDH1A1 P00352 3/20 0.32
HTT P42858 3/20 0.32
RAB9A P51151 3/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
TDP1 Q9NUW8 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
CHRNB4 P30926 1/20 0.32
CHRNA3 P32297 1/20 0.32
CHRNA7 P36544 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
HTR1B P28222 1/20 0.32
GLA P06280 1/20 0.32
RCE1 Q9Y256 1/20 0.32
CNR1 P21554 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrabuthylammonium SCHEMBL11969818 0.95 CHAT (0.33) TLR8GAAKDM4ENPC1ALDH1A1
Tetrabuthylammonium SCHEMBL14672898 0.82 SLC22A1 (0.35) SLC22A1ALDH1A1TDP1
Tetrabuthylammonium SCHEMBL5716017 0.80 CNR1 (0.35) GAAKDM4ETDP1KMT2ACHRNB4
Tetrabuthylammonium SCHEMBL30926103 0.80 HTR1B (0.33) GAAKDM4ETDP1CHRNB4CHRNA3
Tetrabuthylammonium SCHEMBL122008 0.80 HTR1B (0.33) GAAKDM4ETDP1CHRNB4CHRNA3
Tetrabuthylammonium SCHEMBL1811926 0.78 CNR1 (0.35) GAAKDM4ETDP1KMT2ACHRNB4
Tetrabuthylammonium SCHEMBL1350363 0.77 KIF11 (0.44) SLC22A1SMN1; SMN2MEN1KMT2ACYP2C9
Tetrabuthylammonium SCHEMBL3363674 0.76 DNM1 (0.33) SLC22A1ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL8350816 0.73 KIF11 (0.43) SLC22A1ALDH1A1HTTSMN1; SMN2MEN1
Tetrabuthylammonium SCHEMBL6933407 0.72 CNR1 (0.36) KDM4EALDH1A1TDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114316403-B Ultraviolet light crosslinking heat-shrinkable tubing and preparation method thereof 中广核高新核材科技(苏州)有限公司 2023-06-06 CN claimed
CN-114316403-A Ultraviolet light crosslinking heat-shrinkable tube material and preparation method thereof 中广核高新核材科技(苏州)有限公司 2022-04-12 CN disclosed
US-10606212-B2 Selection method for additives in photopolymers COVESTRO DEUTSCHLAND AG (DE) 2020-03-31 US disclosed
US-20180180993-A1 NEW TRIAZINE AS PHOTO INITIATORS AND THEIR PREPARATION COVESTRO DEUTSCHLAND AG (DE) 2018-06-28 US disclosed
EP-3320540-A1 NEW TRIAZINE AS PHOTO INITIATORS AND THEIR PREPARATION Covestro Deutschland AG (DE) 2018-05-16 EP disclosed
US-20170362349-A1 PHOTOPOLYMER COMPRISING A NEW CLASS OF PHOTO INITATOR COVESTRO DEUTSCHLAND AG (DE) 2017-12-21 US disclosed
US-20170199494-A1 SELECTION METHOD FOR ADDITIVES IN PHOTOPOLYMERS COVESTRO DEUTSCHLAND AG (DE) 2017-07-13 US disclosed
WO-2016207161-A1 NEW TRIAZINE AS PHOTO INITIATORS AND THEIR PREPARATION COVESTRO DEUTSCHLAND AG (DE) 2016-12-29 WO disclosed
US-9454130-B2 Photopolymer formulations having the adjustable mechanical modulus GUV COVESTRO DEUTSCHLAND AG (DE) 2016-09-27 US disclosed
US-20160231705-A9 SELECTION METHOD FOR ADDITIVES IN PHOTOPOLYMERS COVESTRO DEUTSCHLAND AG (DE) 2016-08-11 US disclosed
US-20130252140-A1 DIFUNCTIONAL (METH)ACRYLATE WRITING MONOMERS BAYER MATERIALSCIENCE AG (DE) 2013-09-26 US disclosed
US-20130034805-A1 HOLOGRAM RECORDING MATERIAL AND HOLOGRAM RECORDING MEDIUM TDK CORPORATION (JP) 2013-02-07 US disclosed
US-20120237856-A1 SELECTION METHOD FOR ADDITIVES IN PHOTOPOLYMERS BAYER INTELLECTUAL PROPERTY GMBH (DE) 2012-09-20 US disclosed
US-20120231377-A1 PHOTOPOLYMER FORMULATION HAVING DIFFERENT WRITING COMONOMERS COVESTRO DEUTSCHLAND AG (DE) 2012-09-13 US disclosed
US-20120231376-A1 FLUOROURETHANE AS AN ADDITIVE IN A PHOTOPOLYMER FORMULATION BAYER INTELLECTUAL PROPERTY GMBH (DE) 2012-09-13 US disclosed
US-20120219883-A1 METHOD FOR PRODUCING A HOLOGRAPHIC FILM BAYER INTELLECTUAL PROPERTY GMBH (DE) 2012-08-30 US disclosed
US-20120219884-A1 PHOTOPOLYMER FORMULATIONS HAVING THE ADJUSTABLE MECHANICAL MODULUS GUV BAYER INTELLECTUAL PROPERTY GMBH (DE) 2012-08-30 US disclosed
US-20120219885-A1 NOVEL NON-CRYSTALLIZING METHACRYLATES, PRODUCTION AND USE THEREOF BAYER INTELLECTUAL PROPERTY GMBH (DE) 2012-08-30 US disclosed
US-20120214089-A1 METHOD FOR PRODUCING A HOLOGRAPHIC FILM BAYER INTELLECTUAL PROPERTY GMBH (DE) 2012-08-23 US disclosed
US-20120214090-A1 METHOD FOR PRODUCING HOLOGRAPHIC MEDIA BAYER INTELLECTUAL PROPERTY GMBH (DE) 2012-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120219885-A1 NOVEL NON-CRYSTALLIZING METHACRYLATES, PRODUCTION AND USE THEREOF MEP1A, MMAB, RHOA TLR8 4566/4885SLC22A1 4674/4885GAA 1532/4885
US-20120231376-A1 FLUOROURETHANE AS AN ADDITIVE IN A PHOTOPOLYMER FORMULATION UROD, PFN1, UFM1 TLR8 3954/4885SLC22A1 4385/4885GAA 3701/4885
US-20180180993-A1 NEW TRIAZINE AS PHOTO INITIATORS AND THEIR PREPARATION STUB1, BAZ2A, TIPARP TLR8 1191/4885SLC22A1 4821/4885GAA 2622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.